Molecular dissect of IGFBP-3 function on cell growth in prostate cancer cells in vitro and monitoring of IGFBP-3 in response to VD3 treatment, castration or androgen-deprivation therapy in patient’s prostate tumor would be future challenge. This evidence concerns the gene IGFBP3 and prostate carcinoma.